Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Croda International PLC Director's Dealing 2019

Mar 28, 2019

4641_dirs_2019-03-28_eea82c1e-c529-4f70-ab3f-9c7123822470.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 3385U

Croda International PLC

28 March 2019

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Maarten Willem Heijbroek

2

Reason for the notification

a)

Position/status

Member of Executive Committee (PDMR)

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Croda International Plc

b)

LEI

2138004WVNBFJEE0XV26

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 10.357143p each

ISIN:  GB00BYZWX769

b)

Nature of the transaction

Sale

c)

Price(s) and volume(s)

Price(s) Volume(s)
4903p 1,991

d)

Aggregated information

- Aggregated volume

- Price

Aggregated volume Aggregated Price
1,991 £97,618.73

e)

Date of the transaction

2019-03-27

f)

Place of the transaction

XLON

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

DSHFVLFLKXFFBBL